Appetite 30 , 255267 (1998)
Hims & Hers stock plunged around 30% on Monday after drugmaker Novo Nordisk abruptly ended a month-long collaboration to make its weight loss drug Wegovy available on the telehealth company's platform
It includes one-on-one coaching, structured lessons, and accountability check-ins that address food, movement, sleep, and emotional health
While these medications cannot be denied for their weight loss success, they do have some serious concerns
Budget realistically for a full year rather than a first month
Patients who need to start treatment immediately Those with type 2 diabetes (covered indication in most provinces) Patients who prefer a medication with longer real-world safety data Individuals whose insurance covers Ozempic but will not cover future medications Those who achieved satisfactory results on semaglutide previously Patients who can wait for optimal efficacy might consider holding for Retatrutide approval if their condition permits
